Publications by authors named "Zhijie Ni"

Claim this Profile
E
Efficacy of surgical treatment of perianal infection in patients with hematological malignancy.
Jie He, Zhijie Ni, Zhongbo Li

Medicine (Baltimore)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mining and exploration of rehabilitation nursing targets for colorectal cancer.
Ruipu Li, Jie He, Zhijie Ni, Jie Zhang, Xiaoqian Chi

Aging (Albany NY)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intercellular adhesion molecule 1 and selectin l play crucial roles in ulcerative colitis.
Jie He, Zhijie Ni, Zhongbo Li

Medicine (Baltimore)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CALM3 affects the prognosis of leukemia and hemorrhoids.
Jie He, Zhijie Ni, Zhongbo Li

Medicine (Baltimore)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction and internal validation of a novel nomogram for predicting prognosis of infective endocarditis.
Zhao-Jun Yu, Zhi-Jie Ni, Jing Li, Guo-Xing Weng, Zhi Dou

Sci Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
scLRTD : A Novel Low Rank Tensor Decomposition Method for Imputing Missing Values in Single-Cell Multi-Omics Sequencing Data.
Zhijie Ni, Xiaoying Zheng, Xiao Zheng, Xiufen Zou

IEEE/ACM Trans Comput Biol Bioinform· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nomogram for Predicting In-hospital Mortality in Infective Endocarditis Based on Early Clinical Features and Treatment Options.
Zhao-Jun Yu, Zhi Dou, Jing Li, Zhi-Jie Ni, Guo-Xing Weng

Front Cardiovasc Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer's Disease.
Gilbert M Rishton, Gary C Look, Zhi-Jie Ni, Jason Zhang, Yingcai Wang, Nicholas J Izzo

ACS Med Chem Lett· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The complete mitochondrial genome of (Pall.) Kuntze and its phylogenetic implications.
Shunxin Hu, Jingxi Liu, Lizhu Chen, Wei Chen, Yanxiang Li, Zhijie Ni

Mitochondrial DNA B Resour· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Orally Absorbed Prodrugs of the Antibiotic Aztreonam. Design of Novel Prodrugs of Sulfate Containing Drugs. Part 2.
Eric M Gordon, Matthew A J Duncton, Brian J Wang, Longwu Qi, Dazhong Fan, Zhi-Jie Ni

ACS Med Chem Lett· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imidazo[1,2-a]pyridin-6-yl-benzamide analogs as potent RAF inhibitors.
Aaron Smith, Zhi-Jie Ni, Daniel Poon, Zilin Huang, Zheng Chen

Bioorg Med Chem Lett· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3.
Allan S Wagman, Rustum S Boyce, Sean P Brown, Eric Fang, Dane Goff, Zhi-Jie Ni, Sharadha Subramanian

J Med Chem· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model.
Wooseok Han, Daniel L Menezes, Yongjin Xu, Mark S Knapp, Robert Elling, Zhi-Jie Ni

Bioorg Med Chem Lett· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure guided optimization of a fragment hit to imidazopyridine inhibitors of PI3K.
Sabina Pecchi, Zhi-Jie Ni, Wooseok Han, Aaron Smith, Jiong Lan

Bioorg Med Chem Lett· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer.
Matthew T Burger, Sabina Pecchi, Allan Wagman, Zhi-Jie Ni, Mark Knapp, Daniel Menezes

ACS Med Chem Lett· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties.
Xianfeng Li, Suoming Zhang, Yong-Kang Zhang, Yang Liu, Charles Z Ding, Zhi-Jie Ni

Bioorg Med Chem Lett· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-kinase Inhibitors.
Matthew T Burger, Mark Knapp, Allan Wagman, Zhi-Jie Ni, Thomas Hendrickson

ACS Med Chem Lett· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease.
Xianfeng Li, Yong-Kang Zhang, Yang Liu, Suoming Zhang, Charles Z Ding, Zhi-Jie Ni

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease.
Charles Z Ding, Yong-Kang Zhang, Xianfeng Li, Yang Liu, Suoming Zhang, Zhi-Jie Ni

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel macrocyclic HCV NS3 protease inhibitors derived from α-amino cyclic boronates.
Xianfeng Li, Yong-Kang Zhang, Yang Liu, Charles Z Ding, Yasheen Zhou, Zhi-Jie Ni, Lewis E Pennicott

Bioorg Med Chem Lett· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of novel alpha-amino cyclic boronates as inhibitors of HCV NS3 protease.
Xianfeng Li, Yong-Kang Zhang, Yang Liu, Charles Z Ding, Qun Li, Zhi-Jie Ni, Lewis E Pennicott

Bioorg Med Chem Lett· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of tetrahydro-beta-carbolines as inhibitors of the kinesin Eg5.
Paul A Barsanti, Weibo Wang, Zhi-Jie Ni, David Duhl, Nathan Brammeier

Bioorg Med Chem Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors.
Zhi-Jie Ni, Paul Barsanti, Nathan Brammeier, Anthony Diebes, Daniel J Poon

Bioorg Med Chem Lett· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application.
Norman M Kneteman, Amy J Weiner, John O'Connell, Marc Collett, Tiejun Gao, Zhi-Jie Ni, Janine Kline, Daniel Schiller

Hepatology· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress and development of small molecule HCV antivirals.
Zhi-Jie Ni, Allan S Wagman

Curr Opin Drug Discov Devel· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis